Ince and his team found that although TNBC lacks the three
receptors that
fuel most breast cancers — estrogen
receptors, progesterone
receptors, and human epidermal
growth factor
receptor 2 — it does express androgen
receptors (AR) and vitamin D
receptors (VDR).